Weiss Asset Management’s Immunovant, Inc. Warrants expiring 12/18/2024 IMVTW Stock Holding History

Weiss Asset Management’s Portfolio IMVTW Stock Details IMVTW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-199,600	Closed	-$479K	–	313
2020 Q1	$479K	Hold	199,600	–	–	0.08%	119
2019 Q4	$399K	Buy	+199,600	New	+$404K	0.03%	137

Weiss Asset Management's IMVTW Position: Q2 2020 in Review

Weiss Asset Management sold out of Immunovant, Inc. Warrants expiring 12/18/2024 (IMVTW) in Q2 2020, closing a stake of 199,600 shares — an estimated $479K sold.

Weiss Asset Management first reported a position in IMVTW in Q4 2019 and held it in 2 quarters. The position peaked at $479K in Q1 2020. 0 funds tracked by Wall St. Rank hold IMVTW as of Q2 2020.

Weiss Asset Management reported no remaining Immunovant, Inc. Warrants expiring 12/18/2024 position as of Q2 2020 after selling out during the quarter.
Weiss Asset Management sold 199,600 Immunovant, Inc. Warrants expiring 12/18/2024 shares in Q2 2020, an estimated $479K.
Weiss Asset Management first reported a position in Immunovant, Inc. Warrants expiring 12/18/2024 in Q4 2019 and held it in 2 quarters.
Weiss Asset Management's Immunovant, Inc. Warrants expiring 12/18/2024 position peaked at $479K in Q1 2020.
0 funds tracked by Wall St. Rank held Immunovant, Inc. Warrants expiring 12/18/2024 as of Q2 2020.

Based on Weiss Asset Management's 13F filing for Q2 2020, filed 13 Aug 2020.